SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: Barron Von Hymen who wrote (207)3/14/1998 11:00:00 PM
From: synchro  Read Replies (2) | Respond to of 656
 
Again! Abelson in Barron's poured some hot wax onto immunex....just like Forbes. He seems to concede that Enbrel would get FDA approval, but that Hoestch's RA drug would trounce IMNX's offering. What I don't understand is that he said Hoestch's RA drug is a couple years off in the future. Is that true?